Hiroshi NakamuraChief Executive Officer · Essays & perspective
Net sales, year to March 2026
¥271.4 bn
Electronic Materials 53 per cent, Functional Resins 36 per cent, six months of Basic Chemicals 11 per cent
Return on equity, year to March 2026
8.6%
Up from 4.4 per cent in the year to March 2022
Price-to-book ratio, end of June 2026
1.07x
From 0.61x at the end of March 2023
Cross-held listed stakes
41 → 8
April 2022 to March 2026; ¥49.3 billion realised

A chemical company's capital belongs in the plants that earn more than it costs, and its customers deserve the truth about what those plants can measure.

I am the president and chief executive of Hatsuseki Chemical Co., Ltd., a fictional manufacturer listed on the Prime Market of the Tokyo Stock Exchange. We make high-purity acids, etchants and cleaning chemicals that semiconductor fabs use by the tanker-load, and heat-resistant epoxy resins that become the laminates inside circuit boards and package substrates. In the year to March 2026 we reported net sales of ¥271.4 billion and operating income of ¥25.8 billion, with 6,320 colleagues in Japan, Taiwan, South Korea, Thailand and, since this summer, Arizona.

I joined Hatsuseki in 1989 as a process engineer at the Toyama works, where my grandfather and father had both worked on the electrolysis cells that founded the company. I spent fourteen years at Toyama, seven running or helping to run our Yonezawa plant, five in corporate planning in Tokyo and four as president of our Taiwanese subsidiary before leading the Electronic Materials business and, from June 2022, the company. My two predecessors were also promoted from inside, and each chose the man who followed him. I am trying to make sure the next president is chosen more openly than any of us were.

My first four years as president have been an argument about capital and candour. When I took over, our shares traded at about 0.6 times book value, return on equity was 4.4 per cent and we held stakes in 41 listed companies for reasons nobody could fully explain. Four months in, an employee reported that inspection certificates for two resin grades had been altered for years. We told our customers and the market within a week. Since then we have sold most of our cross-held shares, answered an activist investor at a contested general meeting and sold control of the chlor-alkali business my family helped to build.

Certificates corrected in public

We disclosed altered inspection data on 2,140 resin lots within six days of confirming it, before the investigation had finished. The episode cost ¥4.9 billion and about ¥3.6 billion of annual sales from two customers who left. Every certificate in our nine plants is now generated directly from the instrument.

Cross-held stakes cut from 41 to 8

Between April 2022 and March 2026 we sold all or part of 33 cross-held positions for ¥49.3 billion. Their book value fell from ¥54.8 billion, 20 per cent of net assets, to ¥9.6 billion. The proceeds funded ¥36.2 billion of share buybacks and part of the Arizona plant.

Return on equity nearly doubled

Return on equity rose from 4.4 per cent in the year to March 2022 to 8.6 per cent in the year to March 2026. Our price-to-book ratio moved from 0.61 at the end of March 2023 to 1.07 at the end of June 2026.

A founding business sold with its people

We sold 66 per cent of the Toyama chlor-alkali operation to a regional soda maker for ¥18.6 billion. All 1,080 employees transferred with their terms protected for three years, and we kept a long-term supply contract for the acid our electronic chemicals depend on.

Current focus

I am watching the first months of supply from our Arizona plant, which began shipping to a customer's fab in August 2026, and supporting the nomination advisory committee as it narrows eleven internal candidates and two external ones towards a successor who should take over at the June 2028 general meeting.

Conversations I welcome

I intend to remain president until June 2028 and then leave our board altogether. With my board's consent I would consider one independent outside directorship at a Japanese listed manufacturer outside chemicals and semiconductors from 2027, and perhaps two after I retire. I accept a small number of invitations to speak to directors and investors about capital policy and quality governance.

Beyond the page

The record behind the perspective.

In the boardroom

  • Hatsuseki Chemical Co., Ltd.Representative Director, President and CEO · 2020–present
  • Jinzu Electrochemical Co., Ltd.Non-executive director nominated by the 34 per cent shareholder · 2025–present

Formation

  • Bachelor of Engineering, applied chemistryKumotori University · 1987
  • Master of Engineering, inorganic process chemistryKumotori University · 1989
Hiroshi asked the nomination committee to meet his possible successors without him, and then he actually stayed away. In my experience of Japanese boards that is rarer than it should be. He gives us his view of each candidate, including the ones who argue with him, and leaves the decision where it belongs.
Reiko HashizumeFictional independent outside director and chair of the nomination advisory committee, Hatsuseki Chemical Co., Ltd.
The full record ↗

Contact

I intend to remain president until June 2028 and then leave our board altogether. With my board's consent I would consider one independent outside directorship at a Japanese listed manufacturer outside chemicals and semiconductors from 2027, and perhaps two after I retire. I accept a small number of invitations to speak to directors and investors about capital policy and quality governance.

  • Board appointments
  • Speaking invitations